VentriPoint Diagnostics Ltd.
VPT.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 83.71% | 258.56% | 92.54% | 277.74% | 37.86% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 83.71% | 258.56% | 92.54% | 277.74% | 37.86% |
| Cost of Revenue | -- | -- | -- | -100.00% | 4.17% |
| Gross Profit | 102.93% | 321.91% | 123.40% | 481.98% | 42.26% |
| SG&A Expenses | -6.98% | -2.21% | -0.39% | 14.32% | -4.99% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -15.36% | -5.43% | -3.04% | 5.06% | -2.10% |
| Operating Income | 16.78% | 7.94% | 3.98% | -3.03% | 2.51% |
| Income Before Tax | 9.99% | 1.64% | -1.21% | -6.61% | 0.29% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 11.60% | 3.34% | 0.44% | -6.61% | 0.29% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.60% | 3.34% | 0.44% | -6.61% | 0.29% |
| EBIT | 16.78% | 7.94% | 3.98% | -3.03% | 2.51% |
| EBITDA | 16.73% | 7.87% | 3.91% | -3.12% | 2.42% |
| EPS Basic | 13.98% | 4.93% | 1.30% | -6.25% | 0.42% |
| Normalized Basic EPS | 11.56% | 2.88% | 0.00% | -5.71% | 0.68% |
| EPS Diluted | 13.98% | 4.93% | 1.30% | -6.25% | 0.42% |
| Normalized Diluted EPS | 11.56% | 2.88% | 0.00% | -5.71% | 0.68% |
| Average Basic Shares Outstanding | 2.78% | 1.68% | 0.87% | 0.17% | 0.19% |
| Average Diluted Shares Outstanding | 2.78% | 1.68% | 0.87% | 0.17% | 0.19% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |